201 related articles for article (PubMed ID: 25569440)
1. Small-scale high-throughput sequencing-based identification of new therapeutic tools in cystic fibrosis.
Bonini J; Varilh J; Raynal C; Thèze C; Beyne E; Audrezet MP; Ferec C; Bienvenu T; Girodon E; Tuffery-Giraud S; Des Georges M; Claustres M; Taulan-Cadars M
Genet Med; 2015 Oct; 17(10):796-806. PubMed ID: 25569440
[TBL] [Abstract][Full Text] [Related]
2. Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.
Igreja S; Clarke LA; Botelho HM; Marques L; Amaral MD
Hum Mutat; 2016 Feb; 37(2):209-15. PubMed ID: 26553470
[TBL] [Abstract][Full Text] [Related]
3. Fine characterization of the recurrent c.1584+18672A>G deep-intronic mutation in the cystic fibrosis transmembrane conductance regulator gene.
Costantino L; Rusconi D; Soldà G; Seia M; Paracchini V; Porcaro L; Asselta R; Colombo C; Duga S
Am J Respir Cell Mol Biol; 2013 May; 48(5):619-25. PubMed ID: 23349053
[TBL] [Abstract][Full Text] [Related]
4. mRNA-based detection of rare CFTR mutations improves genetic diagnosis of cystic fibrosis in populations with high genetic heterogeneity.
Felício V; Ramalho AS; Igreja S; Amaral MD
Clin Genet; 2017 Mar; 91(3):476-481. PubMed ID: 27174726
[TBL] [Abstract][Full Text] [Related]
5. Exon-skipping antisense oligonucleotides for cystic fibrosis therapy.
Kim YJ; Sivetz N; Layne J; Voss DM; Yang L; Zhang Q; Krainer AR
Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35017301
[TBL] [Abstract][Full Text] [Related]
6. A novel donor splice site in intron 11 of the CFTR gene, created by mutation 1811+1.6kbA-->G, produces a new exon: high frequency in Spanish cystic fibrosis chromosomes and association with severe phenotype.
Chillón M; Dörk T; Casals T; Giménez J; Fonknechten N; Will K; Ramos D; Nunes V; Estivill X
Am J Hum Genet; 1995 Mar; 56(3):623-9. PubMed ID: 7534040
[TBL] [Abstract][Full Text] [Related]
7. Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA.
Sanz DJ; Hollywood JA; Scallan MF; Harrison PT
PLoS One; 2017; 12(9):e0184009. PubMed ID: 28863137
[TBL] [Abstract][Full Text] [Related]
8. Novel mutations and deletions in cystic fibrosis in a tertiary cystic fibrosis center in Istanbul.
Atag E; Bas Ikizoglu N; Ergenekon AP; Gokdemir Y; Eralp EE; Ata P; Ersu R; Karakoc F; Karadag B
Pediatr Pulmonol; 2019 Jun; 54(6):743-750. PubMed ID: 30938940
[TBL] [Abstract][Full Text] [Related]
9. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.
Sharma H; Mavuduru RS; Singh SK; Prasad R
Mol Hum Reprod; 2014 Sep; 20(9):827-35. PubMed ID: 24958810
[TBL] [Abstract][Full Text] [Related]
11. Assessing the residual CFTR gene expression in human nasal epithelium cells bearing CFTR splicing mutations causing cystic fibrosis.
Masvidal L; Igreja S; Ramos MD; Alvarez A; de Gracia J; Ramalho A; Amaral MD; Larriba S; Casals T
Eur J Hum Genet; 2014 Jun; 22(6):784-91. PubMed ID: 24129438
[TBL] [Abstract][Full Text] [Related]
12. Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Zielenski J; Bozon D; Kerem B; Markiewicz D; Durie P; Rommens JM; Tsui LC
Genomics; 1991 May; 10(1):229-35. PubMed ID: 1710599
[TBL] [Abstract][Full Text] [Related]
13. Exon 9 of the CFTR gene: splice site haplotypes and cystic fibrosis mutations.
Dörk T; Fislage R; Neumann T; Wulf B; Tümmler B
Hum Genet; 1994 Jan; 93(1):67-73. PubMed ID: 7505767
[TBL] [Abstract][Full Text] [Related]
14. Systematic Computational Identification of Variants That Activate Exonic and Intronic Cryptic Splice Sites.
Lee M; Roos P; Sharma N; Atalar M; Evans TA; Pellicore MJ; Davis E; Lam AN; Stanley SE; Khalil SE; Solomon GM; Walker D; Raraigh KS; Vecchio-Pagan B; Armanios M; Cutting GR
Am J Hum Genet; 2017 May; 100(5):751-765. PubMed ID: 28475858
[TBL] [Abstract][Full Text] [Related]
15. Whole-gene CFTR sequencing combined with digital RT-PCR improves genetic diagnosis of cystic fibrosis.
Straniero L; Soldà G; Costantino L; Seia M; Melotti P; Colombo C; Asselta R; Duga S
J Hum Genet; 2016 Dec; 61(12):977-984. PubMed ID: 27488443
[TBL] [Abstract][Full Text] [Related]
16. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles.
Steiner B; Truninger K; Sanz J; Schaller A; Gallati S
Hum Mutat; 2004 Aug; 24(2):120-9. PubMed ID: 15241793
[TBL] [Abstract][Full Text] [Related]
17. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Zielenski J; Rozmahel R; Bozon D; Kerem B; Grzelczak Z; Riordan JR; Rommens J; Tsui LC
Genomics; 1991 May; 10(1):214-28. PubMed ID: 1710598
[TBL] [Abstract][Full Text] [Related]
18. Improved detection of CFTR mutations in Southern California Hispanic CF patients.
Wong LJ; Wang J; Zhang YH; Hsu E; Heim RA; Bowman CM; Woo MS
Hum Mutat; 2001 Oct; 18(4):296-307. PubMed ID: 11668613
[TBL] [Abstract][Full Text] [Related]
19. Analysis of alternative splicing patterns in the cystic fibrosis transmembrane conductance regulator gene using mRNA derived from lymphoblastoid cells of cystic fibrosis patients.
Bienvenu T; Beldjord C; Chelly J; Fonknechten N; Hubert D; Dusser D; Kaplan JC
Eur J Hum Genet; 1996; 4(3):127-34. PubMed ID: 8840112
[TBL] [Abstract][Full Text] [Related]
20. Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling.
Le Maréchal C; Audrézet MP; Quéré I; Raguénès O; Langonné S; Férec C
Hum Genet; 2001 Apr; 108(4):290-8. PubMed ID: 11379874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]